JPMorgan Chase & Co. Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $117.00
Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) had its target price increased by JPMorgan Chase & Co. from $104.00 to $117.00 in a research note published on Thursday,Benzinga reports. JPMorgan ...
Wells Fargo & Company Lowers Huntsman (NYSE:HUN) Price Target to $20.00
Huntsman (NYSE:HUN – Get Free Report) had its price objective reduced by stock analysts at Wells Fargo & Company from $22.00 ...